Form 4: Co-Diagnostics Director Eugene Durenard Receives 110,000 Restricted Stock Units
SEC Form 4
Director Eugene Durenard of Co-Diagnostics, Inc. (CODX) was granted 110,000 restricted stock units (RSUs) on April 26, 2024, under the company's 2015 Long Term Incentive Plan.
Summary
- On April 26, 2024, Eugene Durenard, a director of Co-Diagnostics, Inc., was granted 110,000 restricted stock units (RSUs).
- The grant was made pursuant to the Issuer's 2015 Long Term Incentive Plan, as amended.
- Each RSU represents the contingent right to receive one share of Co-Diagnostics' common stock upon vesting.
- The RSUs vest in six installments, commencing on November 23, 2024, and continuing every six months thereafter.
- Following the transaction, Durenard directly owns 230,000 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The grant of RSUs is a standard practice and indicates confidence in the company's future performance. It aligns the director's interests with those of the shareholders.
Positives
- The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing long-term value creation.
- The vesting schedule encourages continued service and commitment from the director.
Industry Context
Grants of restricted stock units are a common practice in corporate governance to incentivize directors and align their interests with those of shareholders. The vesting schedule is designed to encourage long-term commitment and performance.
Comparison to Industry Standards
- RSU grants are a standard form of executive compensation, often benchmarked against peer companies in the diagnostics and biotechnology sectors.
- Companies like QuidelOrtho and Hologic also utilize equity-based compensation to align executive incentives with shareholder value.
- The size of the grant and the vesting schedule are typically determined based on factors such as company performance, industry standards, and individual contributions.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's interests with shareholder value creation.
- Employees: The grant can boost employee morale by demonstrating the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 04/26/2024 | Date of transaction: Grant of 110,000 Restricted Stock Units |
| 04/29/2024 | Date of Form 4 filing |
| 11/23/2024 | First vesting date for the Restricted Stock Units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.